hotspot -WSS

hotspot

author：focus 2025-10-01 00:49:45 - browse：93925

Person wearing a blue glove holding money against a blue backdrop. — Adobe

Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report.

Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.-based Moderna, drugmakers developing new vaccines for infectious diseases received 3.4% of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion, the report said.

In comparison, firms with potential cancer drugs received 38% of venture capital, or $72.6 billion — 12 times as much — during the same period, according to the report by the Biotechnology Innovation Organization, or BIO, the world’s largest biotech trade group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Biotech investment managers search for lucrative opportunities

focus

WSS

What do new weight loss drugs mean for bariatric surgery?

AstraZeneca bets AAV gene therapy will still deliver the goods

Medicare Advantage insurers pressure Biden for bigger payments

Readout LOUD podcast, live from the STAT Breakthrough Summit East

How Long Island became the ‘eugenics capital of the world’

AstraZeneca challenges Medicare drug negotiation program

knowledge

hotspot

leisure time

Alkermes shareholders re

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Psychedelics group wrestles with new pharma identity

NYU Langone launches private ChatGPT for its health care data

In Memoriam: Notable people who died in 2023

Asbestos ban is immediate, but health effects will linger for decades

Tori Bowie and the unacceptable rates of Black maternal death

Neuroscience startup Neumora files for IPO

Walensky prepares to leave CDC — and Congress — behind

Feds fine Medicare Advantage plans for overcharging members

hotspot

Complete sequence of Y chromosome published for first time

Readout Newsletter: Illumina, CRISPR, Regeneron

CDC advisory panel says seniors 'may' get RSV vaccine

Psilocybin's anti

Steward Health Care expansion into Malta flopped

Asbestos ban is immediate, but health effects will linger for decades

focus

focus

knowledge

leisure time